Removal of excess fluid and exudate

"Removal of excess fluid and exudate" is **not a molecular or receptor target** but rather describes a physiological process primarily managed by the **lymphatic system**. The lymphatic system is responsible for collecting excess interstitial fluid (including proteins, waste products, and sometimes exudate from inflammation or injury) from tissues and returning it to the bloodstream[5][7]. This process involves specialized structures such as lymphatic capillaries, vessels, nodes, and ducts—not a single molecule or receptor[1][4][6]. The removal of excess tissue fluid prevents edema (swelling) and supports immune surveillance by filtering pathogens through lymph nodes[3][5]. When this function is impaired—due to congenital issues, surgery, trauma, infection, or cancer—conditions like lymphedema can develop[2][9]. Because "removal of excess fluid and exudate" refers to an overall biological function rather than a specific molecular entity (such as an enzyme, transporter, ion channel, or receptor), it does not fit the definition of a canonical therapeutic target. Therefore: - It should not be listed as a druggable target. - There are no direct interacting drugs; instead therapies may aim to support this process (e.g., manual lymphatic drainage for lymphedema)[9]. - No specific biomarkers exist for this "target," though markers may be used in related disease states. In summary: **"Removal of excess fluid and exudate" is not itself a molecule/receptor/therapeutic target but describes an essential physiological role performed by the lymphatic system. If you are seeking information on drug targets involved in this process (such as specific transporters or receptors within the lymphatics), further specification would be needed.**